🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Canada / NCT06978881
Enrolling by invitation Observational

Magnetoencephalography in Psychosis Program

NCT06978881 · tracked via the Priya Life Science Canada tracker
Phase
Observational
Started
2024-05-08
Last updated
2025-05-18

Condition(s) studied

Schizophrenia DisordersPsychosis

Study summary

This research involves the examination of speech, thinking patterns and symptoms and recordings from brain's activity in patients with schizophrenia. The reserchers are investigating if the electrical waves (recorded indirectly using the resulting magnetic field around our head) are disrupted in psychosis, especially in the language related problems seen in this disorder. To examine language, participants will be asked to complete a speech tasks using the DISCOURSE speech elicitation script in which they will be requested to share their thoughts. For this purpose, the participants will be shown some pictures and asked to describe what they see, discuss a significant event from their life and tell a story in their own words. The description of the pictures and other responses to the tasks will be audio-recorded for later transcription into a written format.

The researches will examine the brain regions using Magnetoencephalography (MEG) and Magnetic Resonance Imaging (MRI). MEG and MRI are both non-invasive functional brain imaging technologies. MRI collects structural information and creates images of the brain while MEG collects magnetic activity from neurons, visualized as brain waves. The MRI machine uses a large magnet to help create images while MEG captures the fluctuations in the small magnetic fields resulting from brain's activity. Participants will also undergo a clinical and neurocognitive assessments.

This project design involves 50 individuals who will take part in the study; 25 affected and 25 healthy volunteers aged 18 to 50 years.

Eligibility

Sex
ALL
Min age
18 Years
Max age
50 Years
Healthy volunteers
Accepted
1. Patients: Inclusion Criteria: * Clinical diagnosis of schizophrenia as per DSM-5 criteria. * Aged between 18 and 50 years. * In a stable phase of the illness (no change in Global Functioning \> 10 units within 1 month before the MEG scan assessed using the Global Assessment of Functioning Scale). Exclusion Criteria: * Inability to speak English or French. * History of head trauma, major neurological disorders (e.g., epilepsy), somatic disorders with neurological complaints (e.g., multiple sclerosis), or intellectual disabilities. * Diagnosis of substance use disorder (current or within the last year) as per DSM-5. * Unsuitable for MRI due to safety concerns (e.g., metal in the body, pregnancy, tinnitus). 2. Healthy Controls Inclusion Criteria: * Healthy volunteers aged between 18 and 50 years. * Matched to patients for age (within 2 years), sex, and parental occupational status (rated by NS-SEC). Exclusion Criteria: * Inability to speak English or French. * History of head trauma, major neurological disorders (e.g., epilepsy), somatic disorders with neurological complaints (e.g., multiple sclerosis), or intellectual disabilities. * Diagnosis of substance use disorder (current or within the last year) as per DSM-5. * Personal or family history of psychotic disorder. * Unsuitable for MRI due to safety concerns (e.g., metal in the body, pregnancy, tinnitus).

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Douglas Mental Health University Institute Montreal Quebec

More Douglas Mental Health University Institute trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06978881 on ClinicalTrials.gov ↗ ← All trials in Canada